Status:
COMPLETED
The Effects of Z-338 in Subjects With and Without Functional Dyspepsia
Lead Sponsor:
Zeria Pharmaceutical
Conditions:
Dyspepsia
Eligibility:
All Genders
18-70 years
Phase:
PHASE2
Brief Summary
To assess in subjects with and without functional dyspepsia the effects of Z-338 on: 1. Type and severity of symptoms a standardized nutrient challenge 2. The gastric nutrient distribution and gastri...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects with functional dyspepsia Positive documented diagnosis of FD via RomeII criteria and three or more moderate symptoms of Gastrointestinal Score
- Subjects with no history of functional dyspepsia Clinical assessment, physical examination and laboratory testing without evidence for relevant abnormality.
- Other protocol-defined inclusion/exclusion criteria may apply.
Exclusion
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
52 Patients enrolled
Trial Details
Trial ID
NCT00298194
Start Date
February 1 2006
Last Update
January 14 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Adelaide Hospital
Adelaide, South Australia, Australia, 5000